カテゴリー： LP Information, 世界, 医療/バイオ

世界の処方用プロトンポンプ阻害剤市場予測 2021年-2026年

【英語タイトル】Global Prescription Proton Pump Inhibitor Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9554）・商品コード：LPI21MY9554
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：95
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「処方用プロトンポンプ阻害剤の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ランソプラゾール、パントプラゾール、ラベプラゾール、その他など、用途別には、病院、研究所、その他などにセグメント区分してまとめました。処方用プロトンポンプ阻害剤のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・処方用プロトンポンプ阻害剤の世界市場概要（サマリー）
・処方用プロトンポンプ阻害剤の企業別販売量・売上
・処方用プロトンポンプ阻害剤の企業別市場シェア
・処方用プロトンポンプ阻害剤の世界市場規模 2016年-2021年：種類別（ランソプラゾール、パントプラゾール、ラベプラゾール、その他）
・処方用プロトンポンプ阻害剤の世界市場規模 2016年-2021年：用途別（病院、研究所、その他）
・処方用プロトンポンプ阻害剤の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・処方用プロトンポンプ阻害剤のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・処方用プロトンポンプ阻害剤のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・処方用プロトンポンプ阻害剤の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・処方用プロトンポンプ阻害剤市場の成長要因・課題・動向
・処方用プロトンポンプ阻害剤の世界市場予測 2021年-2026年
・処方用プロトンポンプ阻害剤の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・処方用プロトンポンプ阻害剤のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・処方用プロトンポンプ阻害剤のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・処方用プロトンポンプ阻害剤の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・処方用プロトンポンプ阻害剤の世界市場予測：種類別（ランソプラゾール、パントプラゾール、ラベプラゾール、その他）
・処方用プロトンポンプ阻害剤の世界市場予測：用途別（病院、研究所、その他）
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Prescription Proton Pump Inhibitor will have significant change from previous year. By the most conservative estimates of global Prescription Proton Pump Inhibitor market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in 2020. Over the next five years the Prescription Proton Pump Inhibitor market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Proton Pump Inhibitor market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Lansoprazole
Pantoprazole
Rabeprazole
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Laboratory
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
AstraZeneca
Cadila Pharmaceuticals
Eisai
Eli Lilly
Janssen
Pfizer
Santarus
Wyeth

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prescription Proton Pump Inhibitor Consumption 2016-2026
2.1.2 Prescription Proton Pump Inhibitor Consumption CAGR by Region
2.2 Prescription Proton Pump Inhibitor Segment by Type
2.2.1 Lansoprazole
2.2.2 Pantoprazole
2.2.3 Rabeprazole
2.2.4 Others
2.3 Prescription Proton Pump Inhibitor Sales by Type
2.3.1 Global Prescription Proton Pump Inhibitor Sales Market Share by Type (2016-2021)
2.3.2 Global Prescription Proton Pump Inhibitor Revenue and Market Share by Type (2016-2021)
2.3.3 Global Prescription Proton Pump Inhibitor Sale Price by Type (2016-2021)
2.4 Prescription Proton Pump Inhibitor Segment by Application
2.4.1 Hospital
2.4.2 Laboratory
2.4.3 Others
2.5 Prescription Proton Pump Inhibitor Sales by Application
2.5.1 Global Prescription Proton Pump Inhibitor Sale Market Share by Application (2016-2021)
2.5.2 Global Prescription Proton Pump Inhibitor Revenue and Market Share by Application (2016-2021)
2.5.3 Global Prescription Proton Pump Inhibitor Sale Price by Application (2016-2021)

3 Global Prescription Proton Pump Inhibitor by Company
3.1 Global Prescription Proton Pump Inhibitor Sales Market Share by Company
3.1.1 Global Prescription Proton Pump Inhibitor Sales by Company (2019-2021)
3.1.2 Global Prescription Proton Pump Inhibitor Sales Market Share by Company (2019-2021)
3.2 Global Prescription Proton Pump Inhibitor Revenue Market Share by Company
3.2.1 Global Prescription Proton Pump Inhibitor Revenue by Company (2019-2021)
3.2.2 Global Prescription Proton Pump Inhibitor Revenue Market Share by Company (2019-2021)
3.3 Global Prescription Proton Pump Inhibitor Sale Price by Company
3.4 Global Manufacturers Prescription Proton Pump Inhibitor Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prescription Proton Pump Inhibitor Product Location Distribution
3.4.2 Players Prescription Proton Pump Inhibitor Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Prescription Proton Pump Inhibitor by Region
4.1 Global Prescription Proton Pump Inhibitor by Region
4.1.1 Global Prescription Proton Pump Inhibitor Sales by Region
4.1.2 Global Prescription Proton Pump Inhibitor Revenue by Region
4.2 Americas Prescription Proton Pump Inhibitor Sales Growth
4.3 APAC Prescription Proton Pump Inhibitor Sales Growth
4.4 Europe Prescription Proton Pump Inhibitor Sales Growth
4.5 Middle East & Africa Prescription Proton Pump Inhibitor Sales Growth

5 Americas
5.1 Americas Prescription Proton Pump Inhibitor Sales by Country
5.1.1 Americas Prescription Proton Pump Inhibitor Sales by Country (2016-2021)
5.1.2 Americas Prescription Proton Pump Inhibitor Revenue by Country (2016-2021)
5.2 Americas Prescription Proton Pump Inhibitor Sales by Type
5.3 Americas Prescription Proton Pump Inhibitor Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Prescription Proton Pump Inhibitor Sales by Region
6.1.1 APAC Prescription Proton Pump Inhibitor Sales by Region (2016-2021)
6.1.2 APAC Prescription Proton Pump Inhibitor Revenue by Region (2016-2021)
6.2 APAC Prescription Proton Pump Inhibitor Sales by Type
6.3 APAC Prescription Proton Pump Inhibitor Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Prescription Proton Pump Inhibitor by Country
7.1.1 Europe Prescription Proton Pump Inhibitor Sales by Country (2016-2021)
7.1.2 Europe Prescription Proton Pump Inhibitor Revenue by Country (2016-2021)
7.2 Europe Prescription Proton Pump Inhibitor Sales by Type
7.3 Europe Prescription Proton Pump Inhibitor Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Prescription Proton Pump Inhibitor by Country
8.1.1 Middle East & Africa Prescription Proton Pump Inhibitor Sales by Country (2016-2021)
8.1.2 Middle East & Africa Prescription Proton Pump Inhibitor Revenue by Country (2016-2021)
8.2 Middle East & Africa Prescription Proton Pump Inhibitor Sales by Type
8.3 Middle East & Africa Prescription Proton Pump Inhibitor Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Prescription Proton Pump Inhibitor Distributors
10.3 Prescription Proton Pump Inhibitor Customer

11 Global Prescription Proton Pump Inhibitor Market Forecast
11.1 Global Prescription Proton Pump Inhibitor Forecast by Region
11.1.1 Global Prescription Proton Pump Inhibitor Forecast by Regions (2021-2026)
11.2.2 Global Prescription Proton Pump Inhibitor Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Prescription Proton Pump Inhibitor Forecast by Type
11.7 Global Prescription Proton Pump Inhibitor Forecast by Application

12 Key Players Analysis
12.1 AstraZeneca
12.1.1 AstraZeneca Company Information
12.1.2 AstraZeneca Prescription Proton Pump Inhibitor Product Offered
12.1.3 AstraZeneca Prescription Proton Pump Inhibitor Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 AstraZeneca Main Business Overview
12.1.5 AstraZeneca Latest Developments
12.2 Cadila Pharmaceuticals
12.2.1 Cadila Pharmaceuticals Company Information
12.2.2 Cadila Pharmaceuticals Prescription Proton Pump Inhibitor Product Offered
12.2.3 Cadila Pharmaceuticals Prescription Proton Pump Inhibitor Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Cadila Pharmaceuticals Main Business Overview
12.2.5 Cadila Pharmaceuticals Latest Developments
12.3 Eisai
12.3.1 Eisai Company Information
12.3.2 Eisai Prescription Proton Pump Inhibitor Product Offered
12.3.3 Eisai Prescription Proton Pump Inhibitor Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Eisai Main Business Overview
12.3.5 Eisai Latest Developments
12.4 Eli Lilly
12.4.1 Eli Lilly Company Information
12.4.2 Eli Lilly Prescription Proton Pump Inhibitor Product Offered
12.4.3 Eli Lilly Prescription Proton Pump Inhibitor Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Eli Lilly Main Business Overview
12.4.5 Eli Lilly Latest Developments
12.5 Janssen
12.5.1 Janssen Company Information
12.5.2 Janssen Prescription Proton Pump Inhibitor Product Offered
12.5.3 Janssen Prescription Proton Pump Inhibitor Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Janssen Main Business Overview
12.5.5 Janssen Latest Developments
12.6 Pfizer
12.6.1 Pfizer Company Information
12.6.2 Pfizer Prescription Proton Pump Inhibitor Product Offered
12.6.3 Pfizer Prescription Proton Pump Inhibitor Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Pfizer Main Business Overview
12.6.5 Pfizer Latest Developments
12.7 Santarus
12.7.1 Santarus Company Information
12.7.2 Santarus Prescription Proton Pump Inhibitor Product Offered
12.7.3 Santarus Prescription Proton Pump Inhibitor Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Santarus Main Business Overview
12.7.5 Santarus Latest Developments
12.8 Wyeth
12.8.1 Wyeth Company Information
12.8.2 Wyeth Prescription Proton Pump Inhibitor Product Offered
12.8.3 Wyeth Prescription Proton Pump Inhibitor Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Wyeth Main Business Overview
12.8.5 Wyeth Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Prescription Proton Pump Inhibitor Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Lansoprazole
Table 3. Major Players of Pantoprazole
Table 4. Major Players of Rabeprazole
Table 5. Major Players of Others
Table 6. Global Prescription Proton Pump Inhibitor Sales by Type (2016-2021) & (K Units)
Table 7. Global Prescription Proton Pump Inhibitor Sales Market Share by Type (2016-2021)
Table 8. Global Prescription Proton Pump Inhibitor Revenue by Type (2016-2021) & ($ million)
Table 9. Global Prescription Proton Pump Inhibitor Revenue Market Share by Type (2016-2021)
Table 10. Global Prescription Proton Pump Inhibitor Sale Price by Type (2016-2021)
Table 11. Global Prescription Proton Pump Inhibitor Sales by Application (2016-2021) & (K Units)
Table 12. Global Prescription Proton Pump Inhibitor Sales Market Share by Application (2016-2021)
Table 13. Global Prescription Proton Pump Inhibitor Value by Application (2016-2021)
Table 14. Global Prescription Proton Pump Inhibitor Revenue Market Share by Application (2016-2021)
Table 15. Global Prescription Proton Pump Inhibitor Sale Price by Application (2016-2021)
Table 16. Global Prescription Proton Pump Inhibitor Sales by Company (2019-2021) & (K Units)
Table 17. Global Prescription Proton Pump Inhibitor Sales Market Share by Company (2019-2021)
Table 18. Global Prescription Proton Pump Inhibitor Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Prescription Proton Pump Inhibitor Revenue Market Share by Company (2019-2021)
Table 20. Global Prescription Proton Pump Inhibitor Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Prescription Proton Pump Inhibitor Producing Area Distribution and Sales Area
Table 22. Players Prescription Proton Pump Inhibitor Products Offered
Table 23. Prescription Proton Pump Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Prescription Proton Pump Inhibitor Sales by Region (2016-2021) (K Units)
Table 27. Global Prescription Proton Pump Inhibitor Sales Market Share by Region (2016-2021)
Table 28. Global Prescription Proton Pump Inhibitor Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Prescription Proton Pump Inhibitor Revenue Market Share by Region (2016-2021)
Table 30. Americas Prescription Proton Pump Inhibitor Sales by Country (2016-2021) & (K Units)
Table 31. Americas Prescription Proton Pump Inhibitor Sales Market Share by Country (2016-2021)
Table 32. Americas Prescription Proton Pump Inhibitor Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Prescription Proton Pump Inhibitor Revenue Market Share by Country (2016-2021)
Table 34. Americas Prescription Proton Pump Inhibitor Sales by Type (2016-2021) & (K Units)
Table 35. Americas Prescription Proton Pump Inhibitor Sales Market Share by Type (2016-2021)
Table 36. Americas Prescription Proton Pump Inhibitor Sales by Application (2016-2021) & (K Units)
Table 37. Americas Prescription Proton Pump Inhibitor Sales Market Share by Application (2016-2021)
Table 38. APAC Prescription Proton Pump Inhibitor Sales by Region (2016-2021) & (K Units)
Table 39. APAC Prescription Proton Pump Inhibitor Sales Market Share by Region (2016-2021)
Table 40. APAC Prescription Proton Pump Inhibitor Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Prescription Proton Pump Inhibitor Revenue Market Share by Region (2016-2021)
Table 42. APAC Prescription Proton Pump Inhibitor Sales by Type (2016-2021) & (K Units)
Table 43. APAC Prescription Proton Pump Inhibitor Sales Market Share by Type (2016-2021)
Table 44. APAC Prescription Proton Pump Inhibitor Sales by Application (2016-2021) & (K Units)
Table 45. APAC Prescription Proton Pump Inhibitor Sales Market Share by Application (2016-2021)
Table 46. Europe Prescription Proton Pump Inhibitor Sales by Country (2016-2021) & (K Units)
Table 47. Europe Prescription Proton Pump Inhibitor Sales Market Share by Country (2016-2021)
Table 48. Europe Prescription Proton Pump Inhibitor Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Prescription Proton Pump Inhibitor Revenue Market Share by Country (2016-2021)
Table 50. Europe Prescription Proton Pump Inhibitor Sales by Type (2016-2021) & (K Units)
Table 51. Europe Prescription Proton Pump Inhibitor Sales Market Share by Type (2016-2021)
Table 52. Europe Prescription Proton Pump Inhibitor Sales by Application (2016-2021) & (K Units)
Table 53. Europe Prescription Proton Pump Inhibitor Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Prescription Proton Pump Inhibitor Sales by Country (2016-2021) & (K Units)
Table 55. Middle East & Africa Prescription Proton Pump Inhibitor Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Prescription Proton Pump Inhibitor Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Prescription Proton Pump Inhibitor Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Prescription Proton Pump Inhibitor Sales by Type (2016-2021) & (K Units)
Table 59. Middle East & Africa Prescription Proton Pump Inhibitor Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Prescription Proton Pump Inhibitor Sales by Application (2016-2021) & (K Units)
Table 61. Middle East & Africa Prescription Proton Pump Inhibitor Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of Prescription Proton Pump Inhibitor
Table 63. Key Application and Potential Industries of Prescription Proton Pump Inhibitor
Table 64. Key Challenges of Prescription Proton Pump Inhibitor
Table 65. Key Trends of Prescription Proton Pump Inhibitor
Table 66. Prescription Proton Pump Inhibitor Distributors List
Table 67. Prescription Proton Pump Inhibitor Customer List
Table 68. Global Prescription Proton Pump Inhibitor Sales Forecast by Region (2021-2026) & (K Units)
Table 69. Global Prescription Proton Pump Inhibitor Consumption Market Forecast by Region
Table 70. Global Prescription Proton Pump Inhibitor Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Prescription Proton Pump Inhibitor Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Prescription Proton Pump Inhibitor Sales Forecast by Country (2021-2026) & (K Units)
Table 73. Americas Prescription Proton Pump Inhibitor Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Prescription Proton Pump Inhibitor Sales Forecast by Region (2021-2026) & (K Units)
Table 75. APAC Prescription Proton Pump Inhibitor Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Prescription Proton Pump Inhibitor Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Europe Prescription Proton Pump Inhibitor Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Prescription Proton Pump Inhibitor Sales Forecast by Country (2021-2026) & (K Units)
Table 79. Middle East & Africa Prescription Proton Pump Inhibitor Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Prescription Proton Pump Inhibitor Sales Forecast by Type (2021-2026) & (K Units)
Table 81. Global Prescription Proton Pump Inhibitor Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Prescription Proton Pump Inhibitor Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Prescription Proton Pump Inhibitor Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Prescription Proton Pump Inhibitor Sales Forecast by Application (2021-2026) & (K Units)
Table 85. Global Prescription Proton Pump Inhibitor Sales Market Share Forecast by Application (2021-2026)
Table 86. Global Prescription Proton Pump Inhibitor Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global Prescription Proton Pump Inhibitor Revenue Market Share Forecast by Application (2021-2026)
Table 88. AstraZeneca Basic Information, Prescription Proton Pump Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 89. AstraZeneca Prescription Proton Pump Inhibitor Product Offered
Table 90. AstraZeneca Prescription Proton Pump Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 91. AstraZeneca Main Business
Table 92. AstraZeneca Latest Developments
Table 93. Cadila Pharmaceuticals Basic Information, Prescription Proton Pump Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 94. Cadila Pharmaceuticals Prescription Proton Pump Inhibitor Product Offered
Table 95. Cadila Pharmaceuticals Prescription Proton Pump Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 96. Cadila Pharmaceuticals Main Business
Table 97. Cadila Pharmaceuticals Latest Developments
Table 98. Eisai Basic Information, Prescription Proton Pump Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 99. Eisai Prescription Proton Pump Inhibitor Product Offered
Table 100. Eisai Prescription Proton Pump Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 101. Eisai Main Business
Table 102. Eisai Latest Developments
Table 103. Eli Lilly Basic Information, Prescription Proton Pump Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 104. Eli Lilly Prescription Proton Pump Inhibitor Product Offered
Table 105. Eli Lilly Prescription Proton Pump Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 106. Eli Lilly Main Business
Table 107. Eli Lilly Latest Developments
Table 108. Janssen Basic Information, Prescription Proton Pump Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 109. Janssen Prescription Proton Pump Inhibitor Product Offered
Table 110. Janssen Prescription Proton Pump Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 111. Janssen Main Business
Table 112. Janssen Latest Developments
Table 113. Pfizer Basic Information, Prescription Proton Pump Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 114. Pfizer Prescription Proton Pump Inhibitor Product Offered
Table 115. Pfizer Prescription Proton Pump Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 116. Pfizer Main Business
Table 117. Pfizer Latest Developments
Table 118. Santarus Basic Information, Prescription Proton Pump Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 119. Santarus Prescription Proton Pump Inhibitor Product Offered
Table 120. Santarus Prescription Proton Pump Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 121. Santarus Main Business
Table 122. Santarus Latest Developments
Table 123. Wyeth Basic Information, Prescription Proton Pump Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 124. Wyeth Prescription Proton Pump Inhibitor Product Offered
Table 125. Wyeth Prescription Proton Pump Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 126. Wyeth Main Business
Table 127. Wyeth Latest Developments
List of Figures
Figure 1. Picture of Prescription Proton Pump Inhibitor
Figure 2. Prescription Proton Pump Inhibitor Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prescription Proton Pump Inhibitor Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Prescription Proton Pump Inhibitor Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Prescription Proton Pump Inhibitor Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Lansoprazole
Figure 10. Product Picture of Pantoprazole
Figure 11. Product Picture of Rabeprazole
Figure 12. Product Picture of Others
Figure 13. Global Prescription Proton Pump Inhibitor Sales Market Share by Type in 2020
Figure 14. Global Prescription Proton Pump Inhibitor Revenue Market Share by Type (2016-2021)
Figure 15. Prescription Proton Pump Inhibitor Consumed in Hospital
Figure 16. Global Prescription Proton Pump Inhibitor Market: Hospital (2016-2021) & (K Units)
Figure 17. Prescription Proton Pump Inhibitor Consumed in Laboratory
Figure 18. Global Prescription Proton Pump Inhibitor Market: Laboratory (2016-2021) & (K Units)
Figure 19. Prescription Proton Pump Inhibitor Consumed in Others
Figure 20. Global Prescription Proton Pump Inhibitor Market: Others (2016-2021) & (K Units)
Figure 21. Global Prescription Proton Pump Inhibitor Sales Market Share by Application (2016-2021)
Figure 22. Global Prescription Proton Pump Inhibitor Revenue Market Share by Application in 2020
Figure 23. Prescription Proton Pump Inhibitor Revenue Market by Company in 2020 ($ Million)
Figure 24. Global Prescription Proton Pump Inhibitor Revenue Market Share by Company in 2020
Figure 25. Global Prescription Proton Pump Inhibitor Sales Market Share by Regions (2016-2021)
Figure 26. Global Prescription Proton Pump Inhibitor Revenue Market Share by Region in 2020
Figure 27. Americas Prescription Proton Pump Inhibitor Sales 2016-2021 (K Units)
Figure 28. Americas Prescription Proton Pump Inhibitor Revenue 2016-2021 ($ Millions)
Figure 29. APAC Prescription Proton Pump Inhibitor Sales 2016-2021 (K Units)
Figure 30. APAC Prescription Proton Pump Inhibitor Revenue 2016-2021 ($ Millions)
Figure 31. Europe Prescription Proton Pump Inhibitor Sales 2016-2021 (K Units)
Figure 32. Europe Prescription Proton Pump Inhibitor Revenue 2016-2021 ($ Millions)
Figure 33. Middle East & Africa Prescription Proton Pump Inhibitor Sales 2016-2021 (K Units)
Figure 34. Middle East & Africa Prescription Proton Pump Inhibitor Revenue 2016-2021 ($ Millions)
Figure 35. Americas Prescription Proton Pump Inhibitor Sales Market Share by Country in 2020
Figure 36. Americas Prescription Proton Pump Inhibitor Revenue Market Share by Country in 2020
Figure 37. Americas Prescription Proton Pump Inhibitor Sales Market Share by Type in 2020
Figure 38. Americas Prescription Proton Pump Inhibitor Sales Market Share by Application in 2020
Figure 39. United States Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 40. Canada Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 41. Mexico Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 42. Brazil Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 43. APAC Prescription Proton Pump Inhibitor Sales Market Share by Region in 2020
Figure 44. APAC Prescription Proton Pump Inhibitor Revenue Market Share by Regions in 2020
Figure 45. APAC Prescription Proton Pump Inhibitor Sales Market Share by Type in 2020
Figure 46. APAC Prescription Proton Pump Inhibitor Sales Market Share by Application in 2020
Figure 47. China Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 48. Japan Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 49. Korea Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 50. Southeast Asia Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 51. India Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 52. Australia Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 53. Europe Prescription Proton Pump Inhibitor Sales Market Share by Country in 2020
Figure 54. Europe Prescription Proton Pump Inhibitor Revenue Market Share by Country in 2020
Figure 55. Europe Prescription Proton Pump Inhibitor Sales Market Share by Type in 2020
Figure 56. Europe Prescription Proton Pump Inhibitor Sales Market Share by Application in 2020
Figure 57. Germany Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 58. France Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 59. UK Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 60. Italy Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 61. Russia Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 62. Middle East & Africa Prescription Proton Pump Inhibitor Sales Market Share by Country in 2020
Figure 63. Middle East & Africa Prescription Proton Pump Inhibitor Revenue Market Share by Country in 2020
Figure 64. Middle East & Africa Prescription Proton Pump Inhibitor Sales Market Share by Type in 2020
Figure 65. Middle East & Africa Prescription Proton Pump Inhibitor Sales Market Share by Application in 2020
Figure 66. Egypt Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 67. South Africa Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 68. Israel Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 69. Turkey Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 70. GCC Country Prescription Proton Pump Inhibitor Revenue Growth 2016-2021 ($ Millions)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles


★調査レポート[世界の処方用プロトンポンプ阻害剤市場予測 2021年-2026年] (コード：LPI21MY9554)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の処方用プロトンポンプ阻害剤市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のIDO阻害剤市場予測 2021年-2026年
    LPI21MY9643 / LP Information / 2021年5月 / LPインフォメーション社の「IDO阻害剤の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、小分子、細胞療法、非公開など、用途別には、がん、アルツハイマー疾患、うつ病、白内障などにセグメント区分してまとめました。IDO阻害剤のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・IDO阻害剤の世界市場概要（サマリー） ・IDO阻害剤の企業別販売量・売上 ・IDO阻害剤の企業別市場シェア ・IDO阻害剤の世界市場規模 2016年-2021年：種類別（小分子、細胞療法、非公開） ・IDO阻害剤の世界市場規模 2016年-2021年：用途別（がん、アルツハイマー疾患、うつ病、白内障） ・IDO阻害剤の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・IDO阻害剤のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of IDO inhibitor will have significant change from previous year. By the most conservative estimates of global IDO inhibitor market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the IDO inhibitor market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of IDO inhibitor market by product type, application, key manufacturers and...
  • 世界のプロトンポンプ阻害薬市場 2019年
    DATA909X13851 / QYResearch / 2019年11月20日 / ※本調査レポートは、プロトンポンプ阻害薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、オメプラゾール、ランソプラゾール、パントプラゾール、ラベプラゾール、その他に、用途別には、病院、研究室、その他にセグメント区分し、プロトンポンプ阻害薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・プロトンポンプ阻害薬の世界市場概要 ・プロトンポンプ阻害薬の製造コスト構成分析 ・プロトンポンプ阻害薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・プロトンポンプ阻害薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・プロトンポンプ阻害薬のセグメント分析（種類別） （オメプラゾール、ランソプラゾール、パントプラゾール、ラベプラゾール、その他）...The global Proton Pump Inhibitor Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Proton Pump Inhibitor Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Proton Pump Inhibitor Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Proton Pump Inhibitor Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のアルファ-1プロテアーゼ阻害剤市場予測 2021年-2026年
    LPI21MY9398 / LP Information / 2021年5月 / LPインフォメーション社の「アルファ-1プロテアーゼ阻害剤の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、溶液、粉末など、用途別には、病院、クリニックなどにセグメント区分してまとめました。アルファ-1プロテアーゼ阻害剤のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・アルファ-1プロテアーゼ阻害剤の世界市場概要（サマリー） ・アルファ-1プロテアーゼ阻害剤の企業別販売量・売上 ・アルファ-1プロテアーゼ阻害剤の企業別市場シェア ・アルファ-1プロテアーゼ阻害剤の世界市場規模 2016年-2021年：種類別（溶液、粉末） ・アルファ-1プロテアーゼ阻害剤の世界市場規模 2016年-2021年：用途別（病院、クリニック） ・アルファ-1プロテアーゼ阻害剤の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・アルファ-1プロテアーゼ阻害剤のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Alpha-1 Proteinase Inhibitor will have significant change from previous year. By the most conservative estimates of global Alpha-1 Proteinase Inhibitor market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in 2020. Over the next five years the Alpha-1 Proteinase Inhibitor market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Alpha-1 Proteinase Inhibitor market by product type,...
  • 世界の高脂血症処方薬市場予測 2021年-2026年
    LPI21MY9642 / LP Information / 2021年5月 / LPインフォメーション社の「高脂血症処方薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、HMG COAレダクターゼ阻害剤、ibフィブリン酸誘導体、ニコチン酸、胆汁酸封鎖剤、コレステロール吸収阻害剤、併用薬物療法など、用途別には、病院、クリニックなどにセグメント区分してまとめました。高脂血症処方薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・高脂血症処方薬の世界市場概要（サマリー） ・高脂血症処方薬の企業別販売量・売上 ・高脂血症処方薬の企業別市場シェア ・高脂血症処方薬の世界市場規模 2016年-2021年：種類別（HMG COAレダクターゼ阻害剤、ibフィブリン酸誘導体、ニコチン酸、胆汁酸封鎖剤、コレステロール吸収阻害剤、併用薬物療法） ・高脂血症処方薬の世界市場規模 2016年-2021年：用途別（病院、クリニック）...According to this latest study, the 2020 growth of Hyperlipidemia Prescription Drugs will have significant change from previous year. By the most conservative estimates of global Hyperlipidemia Prescription Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Hyperlipidemia Prescription Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Hyperlipidemia Prescription Drugs market by product type,...
  • 世界の血管内皮増殖因子阻害剤市場予測 2021年-2026年
    LPI21MY9680 / LP Information / 2021年5月 / LPインフォメーション社の「血管内皮増殖因子阻害剤の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、経口薬、注射など、用途別には、病院、外来手術センター、がん研究所などにセグメント区分してまとめました。血管内皮増殖因子阻害剤のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・血管内皮増殖因子阻害剤の世界市場概要（サマリー） ・血管内皮増殖因子阻害剤の企業別販売量・売上 ・血管内皮増殖因子阻害剤の企業別市場シェア ・血管内皮増殖因子阻害剤の世界市場規模 2016年-2021年：種類別（経口薬、注射） ・血管内皮増殖因子阻害剤の世界市場規模 2016年-2021年：用途別（病院、外来手術センター、がん研究所） ・血管内皮増殖因子阻害剤の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・血管内皮増殖因子阻害剤のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Vascular Endothelial Growth Factor Inhibitor will have significant change from previous year. By the most conservative estimates of global Vascular Endothelial Growth Factor Inhibitor market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Vascular Endothelial Growth Factor Inhibitor market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Vascular...
  • 世界の処方用ペットフード市場予測 2021年-2026年
    LPI21MY5459 / LP Information / 2021年5月 / LPインフォメーション社の「処方用ペットフードの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ドッグフード、キャットフード、その他など、用途別には、体重管理、消化器系ケア、皮膚＆食物アレルギー、腎臓ケア、尿健康などにセグメント区分してまとめました。処方用ペットフードのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・処方用ペットフードの世界市場概要（サマリー） ・処方用ペットフードの企業別販売量・売上 ・処方用ペットフードの企業別市場シェア ・処方用ペットフードの世界市場規模 2016年-2021年：種類別（ドッグフード、キャットフード、その他） ・処方用ペットフードの世界市場規模 2016年-2021年：用途別（体重管理、消化器系ケア、皮膚＆食物アレルギー、腎臓ケア、尿健康） ・処方用ペットフードの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・処方用ペットフードのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Prescription Pet Foods will have significant change from previous year. By the most conservative estimates of global Prescription Pet Foods market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Prescription Pet Foods market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Pet Foods market by product type,...
  • 世界の鎮痛剤輸液ポンプ市場予測 2021年-2026年
    LPI21MY8708 / LP Information / 2021年5月 / LPインフォメーション社の「鎮痛剤輸液ポンプの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、容積式鎮痛輸液ポンプ、携帯型鎮痛輸液ポンプ、注射器鎮痛輸液ポンプなど、用途別には、術後用、事故・外傷、陣痛、癌患者、その他などにセグメント区分してまとめました。鎮痛剤輸液ポンプのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・鎮痛剤輸液ポンプの世界市場概要（サマリー） ・鎮痛剤輸液ポンプの企業別販売量・売上 ・鎮痛剤輸液ポンプの企業別市場シェア ・鎮痛剤輸液ポンプの世界市場規模 2016年-2021年：種類別（容積式鎮痛輸液ポンプ、携帯型鎮痛輸液ポンプ、注射器鎮痛輸液ポンプ） ・鎮痛剤輸液ポンプの世界市場規模 2016年-2021年：用途別（術後用、事故・外傷、陣痛、癌患者、その他） ・鎮痛剤輸液ポンプの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・鎮痛剤輸液ポンプのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Analgesics Infusion Pump will have significant change from previous year. By the most conservative estimates of global Analgesics Infusion Pump market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Analgesics Infusion Pump market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Analgesics Infusion Pump market by product type,...
  • 世界のボート用ウォーターポンプ市場予測 2021年-2026年
    LPI21MY8572 / LP Information / 2021年5月 / LPインフォメーション社の「ボート用ウォーターポンプの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、非自動ポンプ、自動ポンプなど、用途別には、川船、船舶などにセグメント区分してまとめました。ボート用ウォーターポンプのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ボート用ウォーターポンプの世界市場概要（サマリー） ・ボート用ウォーターポンプの企業別販売量・売上 ・ボート用ウォーターポンプの企業別市場シェア ・ボート用ウォーターポンプの世界市場規模 2016年-2021年：種類別（非自動ポンプ、自動ポンプ） ・ボート用ウォーターポンプの世界市場規模 2016年-2021年：用途別（川船、船舶） ・ボート用ウォーターポンプの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ボート用ウォーターポンプのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Water Pump for Boats will have significant change from previous year. By the most conservative estimates of global Water Pump for Boats market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Water Pump for Boats market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Water Pump for Boats...
  • 世界の電動ウォーターポンプ市場予測 2021年-2026年
    LPI21MY0329 / LP Information / 2021年5月 / LPインフォメーション社の「電動ウォーターポンプの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、12V EWP、24V EWPなど、用途別には、エンジン、ターボチャージャー、バッテリー、その他などにセグメント区分してまとめました。電動ウォーターポンプのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・電動ウォーターポンプの世界市場概要（サマリー） ・電動ウォーターポンプの企業別販売量・売上 ・電動ウォーターポンプの企業別市場シェア ・電動ウォーターポンプの世界市場規模 2016年-2021年：種類別（12V EWP、24V EWP）...According to this latest study, the 2020 growth of Electric Water Pump will have significant change from previous year. By the most conservative estimates of global Electric Water Pump market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 854.1 million in 2019. Over the next five years the Electric Water Pump market will register a 10.6% CAGR in terms of revenue, the global market size will reach US$ 1279.5 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Electric Water Pump market by product type,...
  • 世界の飛行機用油圧ポンプ市場予測 2021年-2026年
    LPI21MY5741 / LP Information / 2021年5月 / LPインフォメーション社の「飛行機用油圧ポンプの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、OEM、アフターマーケットなど、用途別には、プロペラ機、ジェット機、回転翼機、その他などにセグメント区分してまとめました。飛行機用油圧ポンプのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・飛行機用油圧ポンプの世界市場概要（サマリー） ・飛行機用油圧ポンプの企業別販売量・売上 ・飛行機用油圧ポンプの企業別市場シェア ・飛行機用油圧ポンプの世界市場規模 2016年-2021年：種類別（OEM、アフターマーケット） ・飛行機用油圧ポンプの世界市場規模 2016年-2021年：用途別（プロペラ機、ジェット機、回転翼機、その他） ・飛行機用油圧ポンプの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・飛行機用油圧ポンプのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Airplane Hydraulic Pump will have significant change from previous year. By the most conservative estimates of global Airplane Hydraulic Pump market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Airplane Hydraulic Pump market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Airplane Hydraulic Pump market by product type,...

    • ◆H&Iグローバルリサーチのお客様（例）◆